Prime Minister Orbán spoke at the inauguration of the Israeli Teva Pharmaceutical Industries LTD’s new Hungarian headquarters in Gödöllő, stating that the pharmaceutical industry is one of Hungary’s most successful trademarks worldwide and the Government will do everything in its power to maintain it.

The Hungarian Prime Minister underlined that be it developments or investments, the Hungarian Government is ready for further cooperation with Teva. He added that the company is also a strategic partner of the people of Hungary, since every seventh sick person in the country owes their recovery to the pharmaceutical products of Teva.

The new factory will produce sterile products, such as hypodermic needles and infusions, as well as producing strategically important oncological products, which were previously scarce commodities throughout Europe.

Prime Minister Orbán stated that everyone who provides opportunities for Hungarians through investment is our ally, and the head of Teva is such a person. Concluding his speech, he said that this investment serves the interests of the investors as well as the employees and the Hungarian economy.

Ambassador of Israel to Hungary, Ilan Mor also spoke at the event, highlighting the importance of cooperation between Hungary and Israel and stated that he is proud that several thousand Hungarians work with and for Teva.

Global Director of Teva Jeremy Levin announced that the company firmly believes in the Hungarian people and in the Hungarian economy. CEO of Teva Hungary Mihály Kaszás emphasised that the sterile centre is equipped with state-of-the-art technology. The 22 billion forint investment resulted in a 15 thousand square meter plant creating 263 new jobs, he said, adding that the plant can also provide a stable background to suppliers. The headquarters in Hungary serves as the European hub for Teva, which has been operating in the country since 1993.

(MTI)